Nucleic Acid Amplification Testing Market: Current Analysis and Forecast (2025-2033)

Global Nucleic Acid Amplification Testing Market Size & Forecast

The Global Nucleic Acid Amplification Testing Market was valued at USD 9,040 million in 2024 and is expected to grow at a strong CAGR of around 10.58% during the forecast period (2025-2033F), driven by the rising prevalence of infectious diseases such as COVID-19, tuberculosis, and STIs, necessitating accurate and early diagnosis.

Nucleic Acid Amplification Testing Market Analysis

Nucleic Acid Amplification Testing (NAAT) is a laboratory technique of molecular diagnostics serving as a method of detecting the existence of particular genetic material (DNA or RNA) of a pathogen, viruses, bacteria, or other microorganisms. It can be used to amplify small amounts of nucleic acid to detectable levels, then identify the early and accurate diagnosis of infectious diseases, genetic diseases, and some cancer diseases. The market for Nucleic Acid Amplification Testing (NAAT) is boosted by the fact that the world has been experiencing an increasing need for accurate, fast, and early diagnosis of infectious diseases, such as COVID-19, HIV, tuberculosis, and STIs.

Global Nucleic Acid Amplification Testing Market Trends

This section discusses the key market trends that are influencing the various segments of the global nucleic acid amplification testing market, as found by our team of research experts.

Rising demand for non-invasive and self-collected sampling kits

The increased preference for non-invasive and self-collected sampling kits is an emerging trend in the Nucleic Acid Amplification Testing (NAAT) market, as these methods are more convenient, private, and easy to use, making them highly attractive for mass screening and in-home diagnostics. They also minimize the number of clinic visits and trained healthcare staff, leading to a decrease in the total cost of healthcare procedures and testing. Self-collection activities were boosted by consumers during the COVID-19 pandemic and contributed to the acceleration of the development of self-collection activities. With personalized medicine and preventive care becoming prevalent, there is a high possibility that the demand for easy-to-use and non-invasive diagnostic devices and solutions will increase vastly.

For instance, in March 2025, Visby Medical™, which is a leading innovator in medical diagnostics, announced that the U.S. Food and Drug Administration (FDA) had granted De Novo authorization for the Visby Medical Women’s Sexual Health Test for over-the-counter (OTC) use. This groundbreaking test enables reliable, rapid, and private at-home testing for Chlamydia, Gonorrhea, and Trichomoniasis, the three most common curable sexually transmitted infections (STIs).

Nucleic Acid Amplification Testing Industry Segmentation

This section provides an analysis of the key trends in each segment of the global nucleic acid amplification testing market report, along with forecasts at the global, regional, and country levels for 2025-2033.

The PCR Testing Technology Segment dominates the Global Nucleic Acid Amplification Testing Market

Based on the technology category, the market is categorized into PCR Tests, INAAT Tests, LCR Tests, and Others. Out of these, the PCR tests currently hold the largest market share in the NAAT market because of their high accuracy and sensitivity, along with popularity in clinical diagnostics. However, Isothermal Nucleic Acid Amplification Technology (INAAT) tests are expected to witness the fastest growth in the coming years, due to the properties of providing results with high speed, without requiring thermal cycling.

The Infectious Disease Testing Segment dominates the Global Nucleic Acid Amplification Testing Market.

Based on the application category, the market is categorized into infectious disease testing, oncology testing, genetic testing, and others. Among these, the infectious disease testing holds the largest share in the NAAT market, because of the extensive global burden expected to be caused by infectious diseases and the potential of NAAT in early diagnosis and outbreak control. However, genetic testing is expected to witness the fastest growth in the coming years, due to the growing trend of personalized medicine, awareness of hereditary diseases, and the overall improvement in the genomic industry.

The North America region dominates the Global Nucleic Acid Amplification Testing Market.

North America holds the highest market share in the global nucleic acid amplification testing (NAAT) Market, owing to the very high healthcare expenditure, sophisticated healthcare infrastructure, and early adoption of novel technologies in diagnostics. Strong research and development, extensive application of molecular diagnostics, and availability of major biotechnology and pharmaceutical institutes are some of the advantages enjoyed by the region. Moreover, the increasing prevalence of infectious diseases, cancer, and genetic defects stimulates the demand for proper and quick ways of testing. Additionally, favourable regulations, greater awareness of healthcare providers, and well-established reimbursement policies are also beneficial in advancing the application of NAAT.

The United States held a Dominant share of the North America Nucleic Acid Amplification Testing Market in 2024

The United States is a major manufacturer in the North American Nucleic Acid Amplification Testing (NAAT) Market, as the United States is considered the leader in biotechnology innovation, early regulatory authorization, and broad adoption of NAAT into clinical practice. The active efforts of the country in controlling infectious diseases surveillance, including the efforts of the CDC and the NIH, led to speeding up the implementation of high-throughput molecular diagnostics in hospitals and state health labs. Also, robust investment in precision medicine and decentralized testing systems met the need to introduce rapid and reliable NAAT platforms.

Nucleic Acid Amplification Testing Industry Competitive Landscape

The global nucleic acid amplification testing market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, geographical expansions, and mergers and acquisitions.

Top Nucleic Acid Amplification Testing Market Companies

Some of the major players in the market are F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Promega Corporation, Abbott Laboratories, GENOMTEC, Hologic, Inc., Ustar Biotechnologies, and SD Biosensor, Inc.

Recent Developments in the Nucleic Acid Amplification Testing Market

• In May 2025– SynOligo Biotechnologies and Lumiphore announced a partnership to provide time-resolved luminescent oligos and assays for the nucleic acid amplification testing market (NAAT). The partnership aims to provide game-changing luminescent lanthanide-based oligo probes for diagnostics and life science research applications.

• In July 2024, Roche announced the acquisition of LumiraDx’s Point of Care technology to enhance its product portfolio in the diagnostics segment. Through this acquisition, Roche complements its diagnostics portfolio with a simple-to-use platform that consolidates a wide range of immunoassay and clinical chemistry tests on a single instrument, with the future potential to expand into molecular testing.

Global Nucleic Acid Amplification Testing Market Report Coverage

Reasons to Buy the Nucleic Acid Amplification Testing Market Report:

• The study includes market sizing and forecasting analysis confirmed by authenticated key industry experts.

• The report briefly reviews overall industry performance at a glance.

• The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, type portfolios, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional level analysis of the industry.

Customization Options:

The Global Nucleic Acid Amplification Testing Market can further be customized as per the requirements or any other market segment. Besides this, UnivDatos understands that you may have your own business needs; hence, feel free to contact us to get a report that completely suits your requirements.